{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:02:26Z","timestamp":1780038146506,"version":"3.53.1"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Due to persistent immune dysfunction, People with HIV (PWH) are at increased risk of more severe infections with SARS-CoV-2 and hospitalizations. In several countries, they were listed as a priority group for receiving anti-SARS-CoV-2 vaccines when these vaccines were in scarce supply. These prophylactic vaccines do not completely prevent infections in vaccinated individuals, especially with a heterologous vaccine strain. However, they persistently reduce the severity of breakthrough infections, hospitalization rates and deaths. Although antiretroviral therapy (ART) suppresses HIV replication below the levels detectable by the assays used routinely in clinical care, it does not eliminate viral reservoirs; a small pool of infected cells carrying HIV proviruses integrated into the genomes of CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells and a subset of myeloid cells. Since vaccines work by stimulating these cells, they may theoretically reactivate latent HIV, increase plasma viremia and modulate the size of the HIV reservoir. The apprehension of HIV reactivation in PWH on ART prompted several studies in the past five years to investigate the impact of anti-SARS-CoV-2 vaccination on the markers of HIV persistence. Collectively, these studies have shown that the vaccination is generally safe in PWH on ART and induces only transient increases in viremia with no measurable impact on the size of the reservoir. However, in PWH with unsuppressed viremia, the vaccination was accompanied by more prolonged increases in viremia and in the frequencies of HIV-infected cells. In this review, we discuss these studies, their outcomes, their implications for HIV cure and propose topics for further research.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1829485","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:10:28Z","timestamp":1780035028000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamics of HIV reservoirs following repeated anti-SARS-CoV-2 vaccination"],"prefix":"10.3389","volume":"17","author":[{"given":"Jessica","family":"Lu","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Health Sciences, McGill University","place":["Montreal, QC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology & Infectious Diseases, Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center, University of Montreal","place":["Montreal, QC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Chomont","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Microbiologie, Infectiologie et Immunologie, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]},{"name":"Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM)","place":["Montreal, QC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia T.","family":"Costiniuk","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Immunity in Global Health, Research Institute of McGill University Health Centre","place":["Montreal, QC, Canada"]},{"name":"Department of Medicine, Division of Infectious Diseases and Chronic Viral Illness Services, McGill University Health Centre","place":["Montreal, QC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4016534","article-title":"COVID-19 outcomes among people with HIV and COVID-19 in New York City","volume":"228","author":"Braunstein","year":"2023","journal-title":"J Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.10.15.21265063","article-title":"Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020","volume":"90","author":"Shapiro","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-022-00618-w","article-title":"COVID-19 outcomes and risk factors among people living with HIV","volume":"19","author":"Spinelli","year":"2022","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1101\/2024.11.03.24316673","article-title":"Global estimates of lives and life-years saved by COVID-19 vaccination during 2020-2024","volume":"6","author":"Ioannidis","year":"2025","journal-title":"JAMA Health Forum"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03278-y","article-title":"SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination","volume":"31","author":"Nguyen","year":"2025","journal-title":"Nat Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1097\/qad.0000000000003429","article-title":"COVID-19 vaccine immunogenicity in people with HIV","volume":"37","author":"Costiniuk","year":"2023","journal-title":"AIDS"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1017\/s095026882300153x","article-title":"Immunogenicity and safety of COVID-19 vaccines among people living with HIV: a systematic review and meta-analysis","volume":"151","author":"Zhao","year":"2023","journal-title":"Epidemiol Infect"},{"key":"B8","doi-asserted-by":"publisher","first-page":"20610","DOI":"10.1038\/s41598-023-47106-8","article-title":"COVID-19 vaccine uptake among people with HIV: identifying characteristics associated with vaccine hesitancy","volume":"13","author":"Boschung","year":"2023","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100566","DOI":"10.2139\/ssrn.4829229","article-title":"Sex differences in COVID-19 vaccine confidence in people living with HIV in Canada","volume":"21","author":"Lu","year":"2024","journal-title":"Vaccine X"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000003882","article-title":"Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapy","volume":"38","author":"Gianella","year":"2024","journal-title":"AIDS"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(02)00511-x","article-title":"Safety and immunogenicity of influenza vaccination in individuals infected with HIV","volume":"20","author":"Zanetti","year":"2002","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000001201","article-title":"Standard vaccines increase HIV-1 transcription during antiretroviral therapy","volume":"30","author":"Yek","year":"2016","journal-title":"AIDS"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2012.0115","article-title":"Short communication: HIV type 1 accumulates in influenza-specific T cells in subjects receiving seasonal vaccination in the context of effective antiretroviral therapy","volume":"28","author":"Jones","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1086\/315260","article-title":"Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy","volume":"181","author":"Gunthard","year":"2000","journal-title":"J Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01966","article-title":"Hepatitis B virus vaccination in HIV-1-infected young adults: a tool to reduce the size of HIV-1 reservoirs","volume":"8","author":"Bekele","year":"2017","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0000000000001829","article-title":"Influenza vaccination can broadly activate the HIV reservoir during antiretroviral therapy","volume":"79","author":"Christensen-Quick","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.11.001","article-title":"The mTOR complex controls HIV latency","volume":"20","author":"Besnard","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/v18020154","article-title":"Potential impact of SARS-CoV-2 spike protein on HIV-1 reservoir in people living with HIV","volume":"18","author":"Federico","year":"2026","journal-title":"Viruses"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-7669683\/v1","article-title":"SARS-CoV-2 S protein activates the HIV latent reservoir through the mTOR pathway","author":"Xu","year":"2025","journal-title":"mBioRxiv"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/v16081310","article-title":"SARS-CoV-2 modulation of HIV latency reversal in a myeloid cell line: direct and bystander effects","volume":"16","author":"Jarmoluk","year":"2024","journal-title":"Viruses"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.122.061025","article-title":"Circulating spike protein detected in post-COVID-19 mRNA vaccine myocarditis","volume":"147","author":"Yonker","year":"2023","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1038\/s41467-022-32376-z","article-title":"SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8(+) T-cells","volume":"13","author":"Stevenson","year":"2022","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1434181","article-title":"COVID-19 vaccines: current and future challenges","volume":"15","author":"Mohammadi","year":"2024","journal-title":"Front Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra2206573","article-title":"Covid-19 vaccines - immunity, variants, boosters","volume":"387","author":"Barouch","year":"2022","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.09.014","article-title":"A global epidemiological analysis of COVID-19 vaccine types and clinical outcomes","volume":"124","author":"Alhinai","year":"2022","journal-title":"Int J Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)32156-5","article-title":"Use of adenovirus type-5 vectored vaccines: a cautionary tale","volume":"396","author":"Buchbinder","year":"2020","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2355683","article-title":"Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: a retrospective cohort study","volume":"20","author":"Jin","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0320779","article-title":"Vaccine effectiveness of inactivated and mRNA COVID-19 vaccine platform during Delta and Omicron wave in Jakarta, Indonesia: a test-negative case-control study","volume":"20","author":"Burhan","year":"2025","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123610","article-title":"Efficacy and limitations of SARS-CoV-2 vaccines - a systematic review","volume":"371","author":"Azeem","year":"2025","journal-title":"Life Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052621","article-title":"HIV reservoirs and treatment strategies toward curing HIV infection","volume":"25","author":"Matsuda","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.08.010","article-title":"Redefining the viral reservoirs that prevent HIV-1 eradication","volume":"37","author":"Eisele","year":"2012","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia","volume":"278","author":"Wong","year":"1997","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy","volume":"94","author":"Chun","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav3491","article-title":"Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection","volume":"12","author":"Leyre","year":"2020","journal-title":"Sci Transl Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1086\/525283","article-title":"Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro","volume":"197","author":"Koelsch","year":"2008","journal-title":"J Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.09.081","article-title":"Identification of genetically intact HIV-1 proviruses in specific CD4(+) T cells from effectively treated participants","volume":"21","author":"Hiener","year":"2017","journal-title":"Cell Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11904-023-00653-1","article-title":"HIV reservoir: how to measure it","volume":"20","author":"Zhang","year":"2023","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-4690-8-52","article-title":"The role of unintegrated DNA in HIV infection","volume":"8","author":"Sloan","year":"2011","journal-title":"Retrovirology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2023.08.006","article-title":"Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4(+) and CD8(+) T cells","volume":"31","author":"Dube","year":"2023","journal-title":"Cell Host Microbe"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad503","article-title":"Plasma human immunodeficiency virus 1 soluble glycoprotein 120 association with correlates of immune dysfunction and inflammation in antiretroviral therapy-treated individuals with undetectable viremia","volume":"229","author":"Benlarbi","year":"2024","journal-title":"J Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.chom.2017.03.008","article-title":"Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes, which shape the proviral landscape","volume":"21","author":"Pollack","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3046-3_16","article-title":"Measuring the frequency of latent HIV-1 in resting CD4(+) T cells using a limiting dilution coculture assay","volume":"1354","author":"Laird","year":"2016","journal-title":"Methods Mol Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/387183a0","article-title":"Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection","volume":"387","author":"Chun","year":"1997","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00609-14","article-title":"Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies","volume":"88","author":"Vandergeeten","year":"2014","journal-title":"J Virol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2013.01.004","article-title":"Quantitation of HIV DNA integration: effects of differential integration site distributions on Alu-PCR assays","volume":"189","author":"Brady","year":"2013","journal-title":"J Virol Methods"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003174","article-title":"Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies","volume":"9","author":"Eriksson","year":"2013","journal-title":"PloS Pathog"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0898-8","article-title":"A quantitative approach for measuring the reservoir of latent HIV-1 proviruses","volume":"566","author":"Bruner","year":"2019","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2651-8","article-title":"Distinct viral reservoirs in individuals with spontaneous control of HIV-1","volume":"585","author":"Jiang","year":"2020","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1172\/jci124291","article-title":"Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy","volume":"129","author":"Einkauf","year":"2019","journal-title":"J Clin Invest"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00099-21","article-title":"Cell-associated HIV-1 unspliced-to-multiply-spliced RNA ratio at 12 weeks of ART predicts immune reconstitution on therapy","volume":"12","author":"Scherpenisse","year":"2021","journal-title":"mBio"},{"key":"B54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12977-018-0397-2","article-title":"What do we measure when we measure cell-associated HIV RNA","volume":"15","author":"Pasternak","year":"2018","journal-title":"Retrovirology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.06.019","article-title":"A novel assay to measure the magnitude of the inducible viral reservoir in HIV-infected individuals","volume":"2","author":"Procopio","year":"2015","journal-title":"EBioMedicine"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000003841","article-title":"Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size","volume":"38","author":"Duncan","year":"2024","journal-title":"AIDS"},{"key":"B57","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12985-023-02086-z","article-title":"Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman","volume":"20","author":"Di Girolamo","year":"2023","journal-title":"Virol J"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30394","article-title":"Increase in HIV reservoir and T cell immune response after CoronaVac vaccination in people living with HIV","volume":"10","author":"Peng","year":"2024","journal-title":"Heliyon"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107915","article-title":"Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV","volume":"26","author":"Matveev","year":"2023","journal-title":"iScience"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/v15122427","article-title":"Effect of SARS-CoV-2 breakthrough infection on HIV reservoirs and T-cell immune recovery in 3-dose vaccinated people living with HIV","volume":"15","author":"Qu","year":"2023","journal-title":"Viruses"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac544","article-title":"Effect of severe acute respiratory syndrome coronavirus 2 vaccine booster on human immunodeficiency virus reservoirs and immune markers","volume":"9","author":"Rai","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.4417076","article-title":"SARS-CoV-2 mRNA vaccine induced immune responses in men with HIV-1 and impact on proviral reservoirs","volume-title":"SSRN","author":"Tuttle","year":"2023"},{"key":"B63","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12879-025-12184-8","article-title":"Effects of inactivated COVID-19 vaccination on HIV viremia and reservoir size: a longitudinal cohort study","volume":"26","author":"Li","year":"2025","journal-title":"BMC Infect Dis"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/id9.0000000000000138","article-title":"Safety profile of COVID-19 vaccines in HIV patients undergoing ART and their impact on immune recovery and HIV reservoirs","volume":"4","author":"Song","year":"2024","journal-title":"Infect Dis Immun"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hiv.70235","article-title":"HIV-1 viral load and reservoir size remain stable following SARS-CoV-2 mRNA vaccination in people with HIV","volume":"26","author":"Kieri","year":"2026","journal-title":"HIV Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad544","article-title":"SARS-CoV-2 mRNA vaccines induce greater complement activation and decreased viremia and Nef antibodies in men with HIV-1","volume":"229","author":"Tuttle","year":"2024","journal-title":"J Infect Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01714-18","article-title":"A simpler and more sensitive single-copy HIV-1 RNA assay for quantification of persistent HIV-1 viremia in individuals on suppressive antiretroviral therapy","volume":"57","author":"Tosiano","year":"2019","journal-title":"J Clin Microbiol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.820126","article-title":"Impact on HIV-1 RNA levels and antibody responses following SARS-CoV-2 vaccination in HIV-infected individuals","volume":"12","author":"Portillo","year":"2021","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13080926","article-title":"The effect of SARS-CoV-2 vaccination on HIV viral load in patients under bictegravir\/tenofovir alafenamide\/emtricitabine therapy: a retrospective observational study","volume":"13","author":"Pipitone","year":"2025","journal-title":"Healthcare (Basel)"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107065","article-title":"SARS-CoV-2 mRNA vaccination and short-term changes in viral load and CD4\/CD8 T-cell counts in people living with HIV","volume":"144","author":"Vergori","year":"2024","journal-title":"Int J Infect Dis"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1668576","article-title":"Immunogenicity and safety of the booster COVID-19 vaccine among people with HIV: a systematic review and meta-analysis","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-10-41","article-title":"Cell-associated HIV RNA: a dynamic biomarker of viral persistence","volume":"10","author":"Pasternak","year":"2013","journal-title":"Retrovirology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","article-title":"Getting the \"kill\" into \"shock and kill\": strategies to eliminate latent HIV","volume":"23","author":"Kim","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3018(18)30039-0","article-title":"Barriers and strategies to achieve a cure for HIV","volume":"5","author":"Pitman","year":"2018","journal-title":"Lancet HIV"},{"key":"B75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.antiviral.2019.03.008","article-title":"HIV \"shock and kill\" therapy: in need of revision","volume":"166","author":"Abner","year":"2019","journal-title":"Antiviral Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.2471\/blt.23.290093","article-title":"Surveillance for variants of SARS-CoV-2 to inform risk assessments","volume":"101","author":"Attar Cohen","year":"2023","journal-title":"Bull World Health Organ"},{"key":"B77","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/cid\/ciab873","article-title":"Sex differences in human immunodeficiency virus persistence and reservoir size during aging","volume":"75","author":"Gianella","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.7024","article-title":"Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US","volume":"182","author":"Sun","year":"2022","journal-title":"JAMA Intern Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0000000000003475","article-title":"COVID-19 breakthrough infections among people with HIV: a statewide cohort analysis","volume":"97","author":"Yang","year":"2024","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071614","article-title":"Breakthrough COVID-19 infections after booster SARS-CoV-2 vaccination in a Greek cohort of people living with HIV during the Delta and Omicron waves","volume":"12","author":"Protopapas","year":"2024","journal-title":"Biomedicines"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100243","article-title":"A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir","volume":"2","author":"Levy","year":"2021","journal-title":"Cell Rep Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1097\/rti.0000000000000528","article-title":"Risk factors for death among the first 80\u2013543 coronavirus disease 2019 (COVID-19) cases in China: relationships between age, underlying disease, case severity, and region","volume":"74","author":"Zhang","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy617","article-title":"Sex-based differences in human immunodeficiency virus type 1 reservoir activity and residual immune activation","volume":"219","author":"Scully","year":"2019","journal-title":"J Infect Dis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02878","article-title":"New frontiers in measuring and characterizing the HIV reservoir","volume":"10","author":"Falcinelli","year":"2019","journal-title":"Front Microbiol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1996.25732.x","article-title":"Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals","volume":"104","author":"Rosok","year":"1996","journal-title":"Clin Exp Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1829485\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:10:30Z","timestamp":1780035030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1829485\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":85,"alternative-id":["10.3389\/fimmu.2026.1829485"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1829485","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1829485"}}